Comparison of Measures to Predict Mortality and Length of Stay in Hospitalized Patients
- PMID: 30882561
- PMCID: PMC6488393
- DOI: 10.1097/NNR.0000000000000350
Comparison of Measures to Predict Mortality and Length of Stay in Hospitalized Patients
Abstract
Background: Patient risk adjustment is critical for hospital benchmarking and allocation of healthcare resources. However, considerable heterogeneity exists among measures.
Objectives: The performance of five measures was compared to predict mortality and length of stay (LOS) in hospitalized adults using claims data; these include three comorbidity composite scores (Charlson/Deyo age-comorbidity score, V W Elixhauser comorbidity score, and V W Elixhauser age-comorbidity score), 3 M risk of mortality (3 M ROM), and 3 M severity of illness (3 M SOI) subclasses.
Methods: Binary logistic and zero-truncated negative binomial regression models were applied to a 2-year retrospective dataset (2013-2014) with 123,641 adult inpatient admissions from a large hospital system in New York City.
Results: All five measures demonstrated good to strong model fit for predicting in-hospital mortality, with C-statistics of 0.74 (95% confidence interval [CI] [0.74, 0.75]), 0.80 (95% CI [0.80, 0.81]), 0.81(95% CI [0.81, 0.82]), 0.94 (95% CI [0.93, 0.94]), and 0.90 (95% CI [0.90, 0.91]) for Charlson/Deyo age-comorbidity score, V W Elixhauser comorbidity score, V W Elixhauser age-comorbidity score, 3 M ROM, and 3 M SOI, respectively. The model fit statistics to predict hospital LOS measured by the likelihood ratio index were 0.3%, 1.2%, 1.1%, 6.2%, and 4.3%, respectively.
Discussion: The measures tested in this study can guide nurse managers in the assignment of nursing care and coordination of needed patient services and administrators to effectively and efficiently support optimal nursing care.
Conflict of interest statement
The authors have no conflicts of interest to report.
References
-
- 3M™ Core Grouping Software. Retrieved December 19, 2017, from https://www.3m.com/3M/en_US/company-us/all-3m-products/~/3M-Core-Groupin...
-
- Averill R, Goldfield N, Steinbeck B, Grant T, Muldoon J, Brough J, & Gay J (1997). Development of the All Patient Refined DRGs (APR-DRGs). St. Paul, MN: 3M; Retrieved March 12, 2017, from https://pdfs.semanticscholar.org/d26f/de2af6c9f56d4460367b4bb6694adbbe9a...
-
- Baram D, Daroowalla F, Garcia R, Zhang G, Chen JJ, Healy E, … Richman P (2008). Use of the All Patient Refined-Diagnosis Related Group (APR-DRG) risk of mortality score as a severity adjustor in the Medical ICU. Clinical Medicine: Circulatory, Respiratory and Pulmonary Medicine, 2, CCRPM-S544. doi:10.4137/ccrpm.s544 - DOI - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources